Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
MSCLF
)
0.3200
UNCHANGED
Streaming Delayed Price
Updated: 3:48 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.3200
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.3200
Today's Range
0.3200 - 0.3200
52wk Range
0.2205 - 0.5701
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 08, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
March 27, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Performance
YTD
-3.00%
-3.00%
1 Month
-23.11%
-23.11%
3 Month
-19.54%
-19.54%
6 Month
+28.00%
+28.00%
1 Year
-30.27%
-30.27%
More News
Read More
Satellos to Present at Upcoming Virtual Investor Conferences in March and April
March 14, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos to Participate in the Leerink Partners Global Biopharma Conference 2024
March 05, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference
March 04, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Announces Upcoming Presentations at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
February 20, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos to Commence Trading on the Toronto Stock Exchange
February 14, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy
February 13, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange
January 16, 2024
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos to Present at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program
November 14, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos to Present at the Stifel 2023 Healthcare Conference
November 02, 2023
From
Satellos Bioscience Inc.
Via
Business Wire
Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer
September 28, 2022
Via
Newsfile
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.